144 related articles for article (PubMed ID: 29571347)
1. Salvage Pulmonary Metastasectomy for Local Relapse After Stereotactic Body Radiotherapy.
Hamaji M; Mitsuyoshi T; Yoshizawa A; Sato T; Matsuo Y; Chen-Yoshikawa TF; Sonobe M; Mizowaki T; Date H
Ann Thorac Surg; 2018 Apr; 105(4):e165-e168. PubMed ID: 29571347
[TBL] [Abstract][Full Text] [Related]
2. Salvage pulmonary resection after stereotactic body radiotherapy: A feasible and safe option for local failure in selected patients.
Antonoff MB; Correa AM; Sepesi B; Nguyen QN; Walsh GL; Swisher SG; Vaporciyan AA; Mehran RJ; Hofstetter WL; Rice DC
J Thorac Cardiovasc Surg; 2017 Aug; 154(2):689-699. PubMed ID: 28495066
[TBL] [Abstract][Full Text] [Related]
3. Salvage stereotactic body radiation therapy (SBRT) for local failure after primary lung SBRT.
Hearn JW; Videtic GM; Djemil T; Stephans KL
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):402-6. PubMed ID: 25017480
[TBL] [Abstract][Full Text] [Related]
4. Salvage radiotherapy with simultaneous integrated boost in non small-cell lung cancer patients with mediastinal relapse after surgery: a pilot study.
Nicosia L; Agolli L; Reverberi C; De Sanctis V; Marinelli L; Minniti G; Di Muzio J; Valeriani M; Osti MF
Radiat Oncol; 2018 Oct; 13(1):207. PubMed ID: 30352607
[TBL] [Abstract][Full Text] [Related]
5. The short-term outcomes of pulmonary metastasectomy or stereotactic body radiation therapy for pulmonary metastasis from epithelial tumors.
Kanzaki R; Suzuki O; Kanou T; Ose N; Funaki S; Shintani Y; Minami M; Tamari K; Otani K; Seo Y; Isohashi F; Ogawa K; Okumura M
J Cardiothorac Surg; 2020 Feb; 15(1):43. PubMed ID: 32103767
[TBL] [Abstract][Full Text] [Related]
6. Salvage stereotactic ablative irradiation for isolated postsurgical local recurrence of lung cancer.
Takeda A; Sanuki N; Eriguchi T; Enomoto T; Yokosuka T; Kaneko T; Handa H; Aoki Y; Oku Y; Kunieda E
Ann Thorac Surg; 2013 Nov; 96(5):1776-82. PubMed ID: 23998410
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
[TBL] [Abstract][Full Text] [Related]
8. Salvage Pulmonary Operations Following Stereotactic Body Radiotherapy for Small Primary and Metastatic Lung Tumors: Evaluation of the Operative Procedures.
Hamakawa H; Takahashi Y; Sakanoue I; Saito T; Date N; Tomii K; Katakami N; Imagunbai T; Kokubo M
Technol Cancer Res Treat; 2018 Jan; 17():1533033818807431. PubMed ID: 30415605
[TBL] [Abstract][Full Text] [Related]
9. Disease-free interval length correlates to prognosis of patients who underwent metastasectomy for esophageal lung metastases.
Shiono S; Kawamura M; Sato T; Nakagawa K; Nakajima J; Yoshino I; Ikeda N; Horio H; Akiyama H; Kobayashi K;
J Thorac Oncol; 2008 Sep; 3(9):1046-9. PubMed ID: 18758309
[TBL] [Abstract][Full Text] [Related]
10. Definitive radiotherapy for hilar and/or mediastinal lymph node metastases after stereotactic body radiotherapy or surgery for stage I non-small cell lung cancer: 5-year results.
Manabe Y; Shibamoto Y; Baba F; Yanagi T; Iwata H; Miyakawa A; Murai T; Okuda K
Jpn J Radiol; 2018 Dec; 36(12):719-725. PubMed ID: 30218253
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy?
Widder J; Klinkenberg TJ; Ubbels JF; Wiegman EM; Groen HJ; Langendijk JA
Radiother Oncol; 2013 Jun; 107(3):409-13. PubMed ID: 23773410
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers.
Neri S; Takahashi Y; Terashi T; Hamakawa H; Tomii K; Katakami N; Kokubo M
J Thorac Oncol; 2010 Dec; 5(12):2003-7. PubMed ID: 21102262
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy for central lung tumors, yes we can!
Korzets Ceder Y; Fenig E; Popvtzer A; Peled N; Kramer MR; Saute M; Bragilovsky D; Schochat T; Allen AM
Radiat Oncol; 2018 Apr; 13(1):77. PubMed ID: 29695273
[TBL] [Abstract][Full Text] [Related]
15. Is stereotactic radiotherapy equivalent to metastasectomy in patients with pulmonary oligometastases?
Li S; Nie S; Li Z; Che G
Interact Cardiovasc Thorac Surg; 2019 Oct; 29(4):544-550. PubMed ID: 31180484
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Body Radiation Therapy as Salvage for Intrathoracic Recurrence in Patients With Previously Irradiated Locally Advanced Non-Small Cell Lung Cancer.
Parks J; Kloecker G; Woo S; Dunlap NE
Am J Clin Oncol; 2016 Apr; 39(2):147-53. PubMed ID: 24457534
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of lymph node metastasis found during pulmonary metastasectomy for extrapulmonary carcinoma.
Ercan S; Nichols FC; Trastek VF; Deschamps C; Allen MS; Miller DL; Schleck CD; Pairolero PC
Ann Thorac Surg; 2004 May; 77(5):1786-91. PubMed ID: 15111187
[TBL] [Abstract][Full Text] [Related]
18. A Retrospective Long-term Follow-up Study of Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer From a Single Institution: Incidence of Late Local Recurrence.
Shintani T; Matsuo Y; Iizuka Y; Mitsuyoshi T; Mizowaki T
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1228-1236. PubMed ID: 29722662
[TBL] [Abstract][Full Text] [Related]
19. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?
Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT
Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626
[TBL] [Abstract][Full Text] [Related]
20. Preliminary report of late recurrences, at 5 years or more, after stereotactic body radiation therapy for non-small cell lung cancer.
Matsuo Y; Shibuya K; Nagata Y; Norihisa Y; Narabayashi M; Sakanaka K; Ueki N; Mizowaki T; Hiraoka M
J Thorac Oncol; 2012 Feb; 7(2):453-6. PubMed ID: 22252562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
